(Q40930210)

24 September 2017

title

The coming of age of the class III antiarrhythmic principle: retrospective and future trends (English)

1 reference

24 September 2017

B N Singh

1

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

American Journal of Cardiology

24 September 2017

published in

1 reference

24 September 2017

volume

78

1 reference

24 September 2017

issue

4A

1 reference

24 September 2017

page(s)

17-27

1 reference

Comparative mechanisms of action of antiarrhythmic drugs

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

The historical development, cellular electrophysiology and pharmacology of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Expanding indications for the use of Class III agents in patients at high risk for sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Choice and chance in drug therapy of cardiac arrhythmias: technique versus drug-specific responses in evaluation of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Controlled trial of sotalol for one year after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Beta-adrenergic blocking property of dl-sotalol maintains class III efficacy in guinea pig ventricular muscle after isoproterenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

A comparison of antiarrhythmic drugs for the suppression of ventricular ectopic depolarizations: A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Five-year follow-up of 589 patients treated with amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Amiodarone and post-MI patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Cardiac arrhythmias and antiarrhythmic drugs: recent advances in our understanding of mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900449-3

10.1016/S0002-9149(96)00449-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference